Bethesda assay/lymphocyte proliferation after FIX challenge. Hemophilia B dogs receiving muscle- or liver-directed AAV-mediated gene therapy were challenged with 2 infusions of cFIX. After challenge, Bethesda assays (A) and lymphocyte proliferation assays (B) were performed.